Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

Teaching Sustainable Development Goals: Methods for Education

January 15, 2025

Funding Opportunities: In Vitro Bioassay Systems Modeling Dysfunction in Neurodegenerative Diseases

January 15, 2025

IVVN ECR Career Development Fellowship Scheme

January 6, 2025

IUIS Executive Committee Statement on Membership Dues

December 20, 2024

ICW 2025 Meeting

December 11, 2024International Complement Society

SLB 2025- Inflammation: A Goldilocks Story

December 10, 2024Society for Leukocyte Biology

Spotlight on Veterinary Immunology: Highlights from ALACI 2024

December 10, 2024Veterinary Immunology Committee (VIC)

Announcing the Recipients of the 2024 Travel4Expertise Grant!

December 2, 2024Gender Equity Committee (GEC)

Clarification on Unaffiliated Events

October 29, 2024